These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30389815)

  • 61. Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).
    Nanni C; Zamagni E; Versari A; Chauvie S; Bianchi A; Rensi M; Bellò M; Rambaldi I; Gallamini A; Patriarca F; Gay F; Gamberi B; Cavo M; Fanti S
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):414-21. PubMed ID: 26475305
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians.
    Karantanis D; Kalkanis D; Czernin J; Herrmann K; Pomykala KL; Bogsrud TV; Subramaniam RM; Lowe VJ; Allen-Auerbach MS
    J Nucl Med; 2014 Dec; 55(12):1925-9. PubMed ID: 25453041
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multimodality imaging in Europe: a survey by the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR).
    Cuocolo A; Breatnach E
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):163-7. PubMed ID: 19915843
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Toward harmonization of clinical molecular diagnostic reports: findings of an international survey.
    Payne DA; Baluchova K; Russomando G; Ahmad-Nejad P; Mamotte C; Rousseau F; van Schaik RHN; Marriott K; Maekawa M; Chan KCA;
    Clin Chem Lab Med; 2018 Dec; 57(1):78-88. PubMed ID: 29729139
    [TBL] [Abstract][Full Text] [Related]  

  • 66. How We Read Oncologic FDG PET/CT.
    Hofman MS; Hicks RJ
    Cancer Imaging; 2016 Oct; 16(1):35. PubMed ID: 27756360
    [No Abstract]   [Full Text] [Related]  

  • 67. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.
    Schmidt-Hansen M; Baldwin DR; Hasler E; Zamora J; Abraira V; Roqué I Figuls M
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009519. PubMed ID: 25393718
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantitative Radiology Reporting in Oncology: Survey of Oncologists and Radiologists.
    Folio LR; Nelson CJ; Benjamin M; Ran A; Engelhard G; Bluemke DA
    AJR Am J Roentgenol; 2015 Sep; 205(3):W233-43. PubMed ID: 26295661
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Positron emission tomography: establishing priorities for health technology assessment.
    Robert G; Milne R
    Health Technol Assess; 1999; 3(16):1-54. PubMed ID: 10632626
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A national survey of computed tomography doses in hybrid PET-CT and SPECT-CT examinations in the UK.
    Iball GR; Bebbington NA; Burniston M; Edyvean S; Fraser L; Julyan P; Parkar N; Wood T
    Nucl Med Commun; 2017 Jun; 38(6):459-470. PubMed ID: 28452797
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [
    Kollberg P; Almquist H; Bläckberg M; Cwikiel M; Gudjonsson S; Lyttkens K; Patschan O; Liedberg F
    Scand J Urol; 2017 Aug; 51(4):308-313. PubMed ID: 28532260
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
    Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
    J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.
    Gebhart G; Gámez C; Holmes E; Robles J; Garcia C; Cortés M; de Azambuja E; Fauria K; Van Dooren V; Aktan G; Coccia-Portugal MA; Kim SB; Vuylsteke P; Cure H; Eidtmann H; Baselga J; Piccart M; Flamen P; Di Cosimo S
    J Nucl Med; 2013 Nov; 54(11):1862-8. PubMed ID: 24092940
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer.
    Riedl CC; Pinker K; Ulaner GA; Ong LT; Baltzer P; Jochelson MS; McArthur HL; Gönen M; Dickler M; Weber WA
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1428-1437. PubMed ID: 28462446
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Practical approach to diagnostic CT combined with PET.
    Wong TZ; Paulson EK; Nelson RC; Patz EF; Coleman RE
    AJR Am J Roentgenol; 2007 Mar; 188(3):622-9. PubMed ID: 17312045
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Radiologists in the United States: demographic, professional, and practice characteristics.
    Deitch CH; Chan WC; Sunshine JH; Owen JB; Shaffer KA
    AJR Am J Roentgenol; 1993 Sep; 161(3):471-8. PubMed ID: 8352090
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PET/CT Response Criteria (European Organization for Research and Treatment of Cancer) Predict Survival Better Than Response Evaluation Criteria in Solid Tumors in Locally Advanced Cervical Cancer Treated With Chemoradiation.
    Yoon JW; Kim S; Kim SW; Kim YT; Kang WJ; Nam EJ
    Clin Nucl Med; 2016 Sep; 41(9):677-82. PubMed ID: 27276204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.